Jane Street’s HUMANIGEN, INC. HGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-19,768
Closed -$2.37K 10332
2022
Q4
$2.37K Sell
19,768
-35,301
-64% -$5.09K ﹤0.01% 8926
2022
Q3
$10K Buy
55,069
+17,899
+48% +$9.63K ﹤0.01% 9355
2022
Q2
$66K Buy
+37,170
New +$83.4K ﹤0.01% 8832
2022
Q1
Sell
-220,695
Closed -$591K 11309
2021
Q4
$821K Sell
220,695
-194,466
-47% -$1.14M ﹤0.01% 6305
2021
Q3
$2.46M Buy
415,161
+178,628
+76% +$2.51M ﹤0.01% 4049
2021
Q2
$4.11M Buy
236,533
+198,855
+528% +$3.62M ﹤0.01% 2990
2021
Q1
$720K Buy
+37,678
New +$688K ﹤0.01% 6110

Other funds holding HGEN

Jane Street's HGEN Position: Q1 2023 in Review

Jane Street sold out of HUMANIGEN, INC. (HGEN) in Q1 2023, closing a stake of 19,768 shares — an estimated $2.37K sold.

Jane Street first reported a position in HGEN in Q1 2021 and held it in 7 quarters. The position peaked at $4.11M in Q2 2021. 42 funds tracked by Wall St. Rank hold HGEN as of Q1 2023.

  • Jane Street reported no remaining HUMANIGEN, INC. position as of Q1 2023 after selling out during the quarter.
  • Jane Street sold 19,768 HUMANIGEN, INC. shares in Q1 2023, an estimated $2.37K.
  • Jane Street first reported a position in HUMANIGEN, INC. in Q1 2021 and held it in 7 quarters.
  • Jane Street's HUMANIGEN, INC. position peaked at $4.11M in Q2 2021.
  • 42 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.